Your chance to participate in the future of immunotherapy!
Since OLEVRA is a privately-owned business, we do not sell shares to the public and we do not disclose public financial information. From time to time OLEVRA collects capital from “accredited investors” within the meaning of applicable law. OLEVRA and especially the “Investor Relations” section receive information about OLEVRA’s securities. This information is for informational purposes only and is regularly updated. This webpage does not provide either a sales offer or a call for a bid to buy units. Such an offer can only be made through the Private Offer Memorandum for the relevant documents and only for investors who fulfill certain conditions.
The company prepares the sale of units by selling them to private persons, including selling them in the United States for the so-called qualified institutional buyers, Rule 144A of the Securities Act of 1933, in the relevant valid wording (the “Securities Act”). The securities mentioned were not and will not be registered under the Securities Act. The investment shares described on this website are not registered under the US Securities Act, the securities laws of the state or the laws of another country. Securities are not offered or sold in the United States or Canada, nor to US citizens or citizens of Canada, except for transactions not included in the registration requirements according to the Securities Act and not subject to it.
Access to the OLEVRA Investor Relations sphere is limited. In order to receive access, please send us your inquiry via the contact form. A member of our Investor Relations team will contact you to verify certain eligibility criteria.